
BrainsWay rose 42.5% from $7.89 to $11.24, ahead of the S&P 500's +11.2%. Its worst day was Jul 29 (−8.6%), and its low came Nov 20 at $7.25.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
BrainsWay closed at its lowest level of the year, 8.1% below where the year started.
−4.0% · S&P 500 −1.5%
BrainsWay shares rose 10.5%, while the S&P 500 rose 0.5%.
+10.5% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
BrainsWay shares rose 10.1%, while the S&P 500 rose 0.6%.
+10.1% · S&P 500 +0.6%
BrainsWay shares rose 9.7%, while the S&P 500 rose 0.7%.
+9.7% · S&P 500 +0.7%
BrainsWay shares rose 8.6%, while the S&P 500 rose 0.2%.
+8.6% · S&P 500 +0.2%
EPS of $0.04 missed the $0.04 estimate on $14.5M revenue (est. $14.0M); FY revenue guidance of $66.0M–$68.0M against the $65.0M consensus.
+8.3% · S&P 500 −0.1%
EPS of $0.06 beat the $0.05 estimate on $15.5M revenue (est. $14.5M); FY revenue guidance of $66.0M–$68.0M against the $66.4M consensus.
−2.6% · S&P 500 +0.6%
BrainsWay shares fell 8.6%, while the S&P 500 fell 1.5%.
−8.6%, the year's worst day · S&P 500 −1.5%
EPS of $0.07 missed the $0.08 estimate on $17.1M revenue (est. $16.5M); FY revenue guidance of $68.0M–$70.0M against the $67.8M consensus.
+10.8%, the year's best day, on 623K shares, the year's heaviest volume · S&P 500 +0.3%
EPS of $0.05 missed the $0.09 estimate on $18.1M revenue (est. $17.9M); FY revenue guidance of $70.0M against the $69.3M consensus.
−8.3% · S&P 500 −0.4%
Where it ended: a close of $11.24 on Nov 11, 2026. Up next: Q4 2026 earnings on Mar 10, 2027 (EPS est. $0.10, revenue est. $18.8M).
Nothing in the past 12 months.
All BWAY dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BWAY and SPY from Benzinga historical bars. Not investment advice.